|
Extramural Support
|
RMS2013 [E]
|
$366,054,072
|
$38,122
|
N/A
|
National Cancer Institute
|
|
Consolidated Basic Cancer Research Program
|
3P30CA010815-44S1
|
$116,998
|
$3,510
|
Altieri, Dario
|
WISTAR INSTITUTE
|
|
Consolidated Basic Cancer Research Program
|
5P30CA010815-44
|
$2,308,335
|
$69,250
|
Altieri, Dario
|
WISTAR INSTITUTE
|
|
Role of IGF-IR tyrosine kinase in NPM-ALK-expressing T-cell lymphoma
|
5R01CA151533-03
|
$308,179
|
$77,045
|
AMIN, HESHAM
|
UT MD ANDERSON CANCER CTR
|
|
Angiogenin-induced RNA cleavage in cancer
|
1R01CA168872-01A1
|
$356,063
|
$178,032
|
ANDERSON, PAUL
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Molecular Oncology of Pediatric, Adolescent and Young Adult Sarcomas
|
ZIA BC 011493
|
$29,021
|
$29,021
|
Arnaldez, Fernanda
|
CCR (NCI)
|
|
Development of Therapeutic Approaches for Wild-Type GIST
|
ZIA BC 011494
|
$9,674
|
$9,674
|
Arnaldez, Fernanda
|
CCR (NCI)
|
|
Host Defense Regulation and Viral Oncogenesis
|
5P01CA128115-05
|
$1,044,934
|
$94,044
|
Barber, Glen
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
AKT-Vimentin interaction; a potential role in soft tissue sarcoma progression and
|
5R01CA138345-05
|
$291,366
|
$291,366
|
BARELI, MENASHE
|
UT MD ANDERSON CANCER CTR
|
|
Studies of amplification in rhabdomyosarcoma
|
ZIA BC 011378
|
$239,910
|
$239,910
|
Barr, Frederic
|
CCR (NCI)
|
|
Studies of gene fusions in rhabdomyosarcoma
|
ZIA BC 011387
|
$287,892
|
$287,892
|
Barr, Frederic
|
CCR (NCI)
|
|
Epigenetic studies in rhabdomyosarcoma
|
ZIA BC 011423
|
$271,898
|
$271,898
|
Barr, Frederic
|
CCR (NCI)
|
|
Cancer Center Support Grant
|
3P30CA042014-24S1
|
$43,750
|
$1,313
|
Beckerle, Mary
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
5P30CA042014-24
|
$1,433,304
|
$42,999
|
Beckerle, Mary
|
UNIVERSITY OF UTAH
|
|
Genome instability and epigenetic deregulation in retinoblastoma and osteosarcoma
|
1K99CA178207-01
|
$102,574
|
$51,287
|
Benavente Arias, Claudia
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Cancer Center Support Grant
|
3P30CA006516-48S1
|
$114,538
|
$1,145
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
3P30CA006516-48S3
|
$12,500
|
$125
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
3P30CA006516-48S4
|
$50,000
|
$500
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
5P30CA006516-48
|
$10,435,722
|
$104,357
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Biological Implications and Translational Applications of HDMX Inhibition
|
ZIA BC 011261
|
$51,885
|
$20,754
|
Bernal, Federico
|
CCR (NCI)
|
|
Antigen-specific T-cell Activation, Application to Vaccines for Cancer and AIDS
|
ZIA SC 004020
|
$2,557,725
|
$127,886
|
Berzofsky, Jay
|
CCR (NCI)
|
|
A mouse model for human gastrointestinal stromal tumor
|
5R01CA102774-09
|
$359,272
|
$359,272
|
BESMER, PETER
|
SLOAN-KETTERING INST CAN RES
|
|
Development of Natural Product Leads as Anticancer Therapeutics
|
ZIA BC 011470
|
$224,699
|
$22,470
|
Beutler, John
|
CCR (NCI)
|
|
JHU ICMIC Program
|
5P50CA103175-08
|
$1,519,395
|
$182,327
|
Bhujwalla, Zaver
|
JOHNS HOPKINS UNIVERSITY
|
|
Improving etoposide treatment of Ewing's sarcoma
|
5R01CA152063-03
|
$291,101
|
$291,101
|
BISHOP, ALEXANDER
|
UNIV OF TX HSC, SA
|
|
Osteosarcoma in Dogs as a Model for the Development of Drugs to Treat Micro-metas
|
1R43CA167887-01A1
|
$266,172
|
$266,172
|
Brewer, George
|
CYPRIS, LLC
|
|
The role of pRb-dependent Ihh in osteogenesis and osteosarcoma
|
5F31CA168132-02
|
$38,188
|
$19,094
|
Bryan, Crystal
|
TUFTS UNIVERSITY BOSTON
|
|
Innate anti-tumor immune responses
|
3R01CA157885-03S1
|
$47,079
|
$14,124
|
BUI, JACK
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Innate anti-tumor immune responses
|
5R01CA157885-03
|
$294,953
|
$88,486
|
BUI, JACK
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Design and Synthesis of HIV Integrase as Potential Anti-AIDS Drugs
|
ZIA BC 007363
|
$229,431
|
$114,715
|
Burke, Terrence
|
CCR (NCI)
|
|
Investigation of Protein-Protein Interactions in the ERAD Ubiquitylation Pathway
|
ZIA BC 011131
|
$650,833
|
$260,333
|
Byrd, R. Andrew
|
CCR (NCI)
|
|
Cancer Center Support Grant
|
3P30CA016058-37S1
|
$121,802
|
$1,218
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA016058-37S2
|
$12,500
|
$125
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
Cancer Center Support Grant
|
5P30CA016058-37
|
$4,284,455
|
$42,845
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
Strategies to Improve Kaposi's Sarcoma Outcomes in Zimbabwe
|
5R01CA172050-02
|
|
$0
|
Campbell, Thomas
|
UNIVERSITY OF COLORADO DENVER
|
|
Molecular Pathogenic Mechanism of Rhabdomyosarcoma
|
ZIA BC 011189
|
$48,071
|
$48,071
|
Cao, Liang
|
CCR (NCI)
|
|
Preclinical Development of Novel Targeted Therapeutics Against Pediatric Sarcoma
|
ZIC BC 011048
|
$192,283
|
$115,370
|
Cao, Liang
|
CCR (NCI)
|
|
The Role of miRNA-mediated RNAI in the Biology of Cancer
|
ZIA BC 010612
|
$133,707
|
$26,741
|
Caplen, Natasha
|
CCR (NCI)
|
|
The Induction of Gene-specific RNAi Against Cancer-associated Genes
|
ZIA BC 010613
|
$222,844
|
$11,142
|
Caplen, Natasha
|
CCR (NCI)
|
|
RNAi Screening for the Systematic Discovery of Cancer Gene Function
|
ZIA BC 010615
|
$222,844
|
$11,142
|
Caplen, Natasha
|
CCR (NCI)
|
|
RNAi Analysis and Screening for Study of Genes and Anti-Cancer Treatments
|
ZIA BC 010939
|
$311,982
|
$15,599
|
Caplen, Natasha
|
CCR (NCI)
|
|
Effects of genetic polymorphism in MHC, KIR, and related loci on human disease
|
ZIA BC 010791
|
$721,737
|
$72,174
|
Carrington, Mary
|
CCR (NCI)
|
|
Impact of HIV and HHV-8 Co-Infection on Antiretroviral Therapy Efficacy in Africa
|
5R01CA138165-04
|
$282,976
|
$282,976
|
CASPER, COREY
|
FRED HUTCHINSON CAN RES CTR
|
|
Modeling KSHV latency in vivo
|
5R01CA103646-07
|
$308,788
|
$308,788
|
CESARMAN, ETHEL
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
|
Targeting vFLIP for the treatment of KSHV-associated malignancies
|
5R01CA154228-03
|
$329,635
|
$247,226
|
CESARMAN, ETHEL
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
|
Conference Support for 16th International Workshop on KSHV and Related Agents, Pu
|
1R13CA177329-01
|
$7,000
|
$7,000
|
Chandran, Bala
|
ROSALIND FRANKLIN UNIV OF MEDICINE & SCI
|
|
Early events of in vitro KSHV infection
|
5R01CA168472-02
|
$301,353
|
$301,353
|
Chandran, Bala
|
ROSALIND FRANKLIN UNIV OF MEDICINE & SCI
|
|
Laboratory of Translational Genomics
|
ZIA CP010201-10410
|
$1,892,992
|
$189,299
|
Chanock, Stephen
|
DCEG (NCI)
|
|
Elucidating the roles of ETV1 in the pathogenesis of GIST
|
5K08CA151660-03
|
$169,589
|
$169,589
|
Chi, Ping
|
SLOAN-KETTERING INST CAN RES
|
|
Bone and Soft Tissue Tumor Etiology: Role and Function of TRE17/USP6
|
1R01CA168452-01A1
|
$266,216
|
$133,108
|
Chou, Margaret
|
CHILDREN'S HOSP OF PHILADELPHIA
|
Total relevant funding to Sarcoma for this search: $59,276,593
|